Gut microbiota in the pathogenesis and treatment of inflammatory bowel disease: a critical review of mechanisms and therapeutic advances - PubMed
a day ago
- #microbiota-targeted therapies
- #inflammatory bowel disease
- #gut microbiota
- Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC), and its global prevalence is increasing.
- Dysbiosis of gut microbiota is strongly correlated with the occurrence and progression of IBD.
- The review focuses on how gut microbiota dysbiosis contributes to IBD pathogenesis.
- Latest research on microbiota-targeted therapies for IBD is synthesized, highlighting their potential and limitations.
- High-quality sources like clinical trials, meta-analyses, and systematic reviews are used to provide an up-to-date perspective.